The American Society for Reproductive Medicine published a report that concludes preimplantation genetic testing for ...

The lifecycle of a medical device is under renewed regulatory and commercial scrutiny. Although lifetime expectations are not ...

The U.S. FDA has cleared Tessera Therapeutics Inc.’s IND application for TSRA-196, its lead in vivo gene editing therapy for α-1 antitrypsin deficiency (AATD). The Australian Human Research Ethics ...

The study shows that personalized medicine demands new competences that extend beyond traditional medical training.

This collaborative project with Montefiore Einstein’s Center for Bioethics aims to ensure that hospital ethics consultation and mediation practices are informed by the needs and values of the Bronx ...

Some of the reasons that friends and strangers alike blame victims for sexual assault may surprise you and make you very ...

Texas Oncology is now offering Texoma residents access to clinical trials for cancer treatment. Texas Oncology provides ...

Identifying copyright holders and response times are major challenges in COA licensing, causing delays in clinical trials. Clear documentation of copyright ownership and standardized response times ...

Mergers and acquisitions can transform a company’s future. For family businesses, those decisions hinge on more than ...

A new healthcare study by MESH warns that many medical protein powders sold in India contain dangerous levels of cadmium, ...

The Phase 1/2 trial is a first-in-human, open-label, multi-national study designed to evaluate the safety, tolerability, and efficacy of TSRA-196 in adults with AATD. Trial participants will receive a ...

As someone who finds the field of science fascinating, I often consider the roles that human and veterinary medicine play in advancing science, particularly through cardiac surgical programs. With ...